FDA Faces ‘Catastrophic Collapse’ as Massive Layoffs Endanger User Fee Program

The FDA derives just under half of its yearly funding from pharma user fees, which help support its operations and fund employee salaries. An analysis from Agency IQ suggests that the agency is dangerously close to losing it all.